TNDM
$22.11
Revenue | $249.25Mn |
Net Profits | $-21.17Mn |
Net Profit Margins | -8.49% |
Tandem Diabetes Care, Inc.’s revenue fell -31.39% since last year same period to $249.25Mn in the Q3 2025. On a quarterly growth basis, Tandem Diabetes Care, Inc. has generated 3.56% jump in its revenue since last 3-months.
Tandem Diabetes Care, Inc.’s net profit jumped 8.97% since last year same period to $-21.17Mn in the Q3 2025. On a quarterly growth basis, Tandem Diabetes Care, Inc. has generated 59.61% jump in its net profits since last 3-months.
Tandem Diabetes Care, Inc.’s net profit margin fell -32.67% since last year same period to -8.49% in the Q3 2025. On a quarterly growth basis, Tandem Diabetes Care, Inc. has generated 61% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.34 |
EPS Estimate Current Year | -0.34 |
Tandem Diabetes Care, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.34 - a 16.2% jump from last quarter’s estimates.
Tandem Diabetes Care, Inc.’s earning per share (EPS) estimates for the current year stand at -0.34.
Earning Per Share (EPS) | 0 |
Tandem Diabetes Care, Inc.’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Tandem Diabetes Care, Inc. has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-11-06 | -0.34 | 0 | 100% |
2025-04-30 | -0.61 | -0.67 | -9.46% |
2025-08-06 | -0.4 | -0.78 | -95% |